Indian Journal of Drugs in Dermatology

REVIEW ARTICLE
Year
: 2019  |  Volume : 5  |  Issue : 1  |  Page : 6--13

Janus Kinase Inhibitors in Dermatology


Aditya Kumar Bubna 
 Department of Dermatology, IQ City Medical College, Durgapur, West Bengal, India

Correspondence Address:
Dr. Aditya Kumar Bubna
IQ City Medical College, Sovapur, Bijra Road, Jemua, Durgapur - 713 206, West Bengal
India

Janus kinase (JAK) inhibitors are a new addition in the armamentarium of drugs in the treatment of autoimmune dermatoses. They have proven to be valuable in treating a variety of inflammatory dermatoses with lesser side effects compared to their biological counterparts. This review throws light on JAK inhibitors and their role in dermatologic diseases.


How to cite this article:
Bubna AK. Janus Kinase Inhibitors in Dermatology.Indian J Drugs Dermatol 2019;5:6-13


How to cite this URL:
Bubna AK. Janus Kinase Inhibitors in Dermatology. Indian J Drugs Dermatol [serial online] 2019 [cited 2019 Oct 17 ];5:6-13
Available from: http://www.ijdd.in/article.asp?issn=2455-3972;year=2019;volume=5;issue=1;spage=6;epage=13;aulast=Bubna;type=0